Syntrophy AI AB is a Sweden-based biotech platform company driving the future of drug discovery and biomedical innovation. By combining artificial intelligence along with moving towards to integration of quantum computing, we are transforming how therapies are discovered, optimized, and delivered. Our cross-border operations in Sweden and India allow us to offer scalable, cost-effective solutions that bridge deep scientific research with real-world application.

We specialize in two core areas:

1. AI + Quantum Drug Discovery, where we accelerate the identification of drug targets and molecules through intelligent computation.
2. AI Modeling for Life Sciences, where we build advanced tools to analyze omics data and support next-generation therapies like cell and gene therapy.

At Syntrophy AI, we aim to unlock the full potential of complex biological data to make drug discovery/precision medicine faster, smarter, and more accessible to all.

Currently we aim to build a platform based on publicly available millions of drug discovery research findings, transcriptomic and proteomic datasets.